Protalix Biotherapeutics Inc Cash Flow Quality Index
Protalix Biotherapeutics Inc cash flow quality index. Protalix Biotherapeutics Inc (PLX) has a Cash Flow Quality Index of 1.85x as of December 2025. Operating cash flow of $2.03 Million exceeds net income of $1.10 Million, indicating high earnings quality where cash backs reported profits. See PLX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Protalix Biotherapeutics Inc (1996–2024)
Cash flow quality index of Protalix Biotherapeutics Inc from 1996 to 2024. Historical Cash Flow Quality Index for Protalix Biotherapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Protalix Biotherapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Protalix Biotherapeutics Inc Cash Flow Quality Index by Year (1996–2024)
Protalix Biotherapeutics Inc cash flow quality index by year from 1996 to 2024. Year-by-year earnings quality comparison for Protalix Biotherapeutics Inc. For the full cash flow conversion analysis, see PLX cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.96x | $8.67 Million | $2.93 Million | ▲ +1965.7% |
| 2023 | -0.16x | $-1.32 Million | $8.31 Million | ▲ +92.4% |
| 1997 | -2.09x | $-247.92K | $118.44K | ▼ -579.4% |
| 1996 | -0.31x | $-40.57K | $131.68K | — |